GNCA News and Press, Genocea Biosciences Inc. From 07/30/20

Webcast/conference call scheduled today, July 30th at 8:00 a.m. EDT Three of five patients achieved separate RECIST responses after GEN-009 administration GEN-009 elicited antigen-specific CD4 + and CD8 + T cell responses in 100% of treated patients CAMBRIDGE, Mass., July 30, ...

MediciNova (NASDAQ: MNOV )   -21% . More news on: MediciNova, Inc., Wilhelmina International, Inc., Allena Pharmaceuticals, Inc., Stocks on the move, , Read more ...

Socket Mobile (NASDAQ: SCKT ) +142%  on launching 2 barcode scanners. More news on: Socket Mobile, Inc., Wilhelmina International, Inc., TCR2 Therapeutics Inc., Stocks on the move, , Read more ...

Gainers:  Global Eagle Entertainment ENT  +164% . More news on: Hamilton Beach Brands Holding Company, Wilhelmina International, Inc., Oncternal Therapeutics, Inc., Stocks on the move, , Read more ...

Genocea Biosciences, Inc. (GNCA) Q2 2020 Results Conference Call July 23, 2020 08:30 AM ET Company Participants Dan Ferry - IR, LifeSci Advisors Chip Clark - President and CEO Diantha Duvall - CFO Tom Davis - Chief Medical Officer Jessica Flechtner - Chief Scientific Officer ...

Genocea Biosciences ( GNCA ) Q2 results : More news on: Genocea Biosciences, Inc., Healthcare stocks news, Stocks on the move, Read more ...

Genocea Biosciences (NASDAQ: GNCA ) : Q2 GAAP EPS of -$0.39 beats by $0.01 . More news on: Genocea Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

Upcoming GEN-009 data update planned for July 30th at 8 a.m. EDT Filed IND application for GEN-011 and is working with the FDA to provide additional information Private Placement with Leading Life Science Investment Funds Conference call today at 8:30 a.m. EDT CAMBRIDGE,...

Genocea Biosciences ( GNCA +1.8% ) has  announced a private placement of up to ~$80M. The company will offer 21.4M shares and 12.2M pre-funded warrants; the 4-year warrants will have an exercise price of $2.25 per share. More news on: Genocea Biosciences, Inc., Healthcare stock...

CAMBRIDGE, Mass., July 22, 2020 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today announced that it has entered into a private placement led by an undisclosed leading U.S. public investment fund...